During a press conference at the White House, Novo Nordisk executive Gordon Findlay suddenly collapsed while standing behind President Donald Trump. The event was focused on announcing a new deal for weight-loss medications.
Findlay's knees buckled unexpectedly, and administration officials along with pharmaceutical representatives quickly intervened to prevent him from falling to the floor.
White House Press Secretary Karoline Leavitt addressed the incident during the "Most Favored Nations Oval Office Announcement," explaining that a company representative fainted. She confirmed that on-site medical personnel responded promptly, and the individual was reported to be okay.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Press witnesses reported that Dr. Mehmet Oz, Administrator for Centers for Medicare & Medicaid Services, helped Findlay safely to the ground to protect his head from injury. Afterwards, reporters were directed out of the Oval Office as cabinet members attended to Findlay and elevated his legs.
The incident was handled swiftly with medical support, allowing the press conference to continue without further interruption.
The sudden collapse of a top executive during a White House event highlighted rapid medical response and calm management under pressure.